510 results on '"de Montalembert M"'
Search Results
2. P-010: TREATMENTS FOR SICKLE CELL DISEASE (SCD) AND THE HEALTHCARE PROFESSIONAL (HCP)–PATIENT RELATIONSHIP: HCP OPINIONS FROM THE INTERNATIONAL SICKLE CELL WORLD ASSESSMENT SURVEY (SWAY)
3. O-02: RADIOMICS AND ARTIFICIAL INTELLIGENCE FOR IDENTIFICATION AND MONITORING OF SILENT CEREBRAL INFARCTS IN SICKLE CELL DISEASE: FIRST ANALYSIS FROM THE GENOMED4ALL EUROPEAN PROJECT
4. P-027: SICKLE CELL DISEASE AND AUTOIMMUNE LIVER DISORDERS: SHOULD HEMATOPOIETIC STEM CELL TRANSPLANTATION BE DISCUSSED EARLY?
5. O-11: AUTOMATED QUANTIFICATION OF POCKED RED BLOOD CELLS CORRELATES WITH SPLEEN SIZE IN SICKLE CELL DISEASE
6. P-090: IS A DEDICATED MARKETING APPROVAL OF HYDROXYUREA IN SICKLE CELL DISEASE MAY INCREASE THE CLINICAL BENEFIT OF THE DRUG?
7. P-032: INTEGRATIVE DIAGNOSIS OF SICKLE CELL DISEASE PATIENTS FOR PERSONALIZED MEDICINE
8. Disponibilité et coût des traitements de base de la drépanocytose dans 13 pays africains
9. Transfusing children with hemoglobinopathies
10. 5612617 EFFICACY AND SAFETY OF A SINGLE DOSE OF EXAGAMGLOGENE AUTOTEMCEL FOR TRANSFUSION-DEPENDENT-THALASSEMIA AND SEVERE SICKLE CELL DISEASE
11. 5612992 SICKLE CELL HEALTH AWARENESS, PERSPECTIVES, AND EXPERIENCES (SHAPE) SURVEY: FINDINGS ON THE BURDEN OF SICKLE CELL DISEASE AND IMPACT ON THE QUALITY OF LIFE OF PATIENTS AND CAREGIVERS IN THE UK
12. Management of iron overload in hemoglobinopathies
13. ERICA– an instrument to measure individual and collective regulation of learning
14. Defining global strategies to improve outcomes in sickle cell disease: a Lancet Haematology commission
15. Étude SHAPE (Sickle cell Health Awareness, Perspectives and Experience) : résultats de l’enquête sur le fardeau de la drépanocytose pour les patients et leurs besoins non satisfaits, rapportés par les professionnels de santé
16. Étude SHAPE (Sickle Cell Health Awareness, Perspectives and Experiences) : enquête sur le fardeau de la drépanocytose et les besoins non satisfaits rapportés par les patients et les aidants
17. Drépanocytose et atteinte vasculaire cérébrale chez l’enfant
18. P1496: OPERATOR-INDEPENDENT, FLUORESCENCE-BASED QUANTIFICATION OF POCKED RED CELLS CORRELATES WITH SPLEEN SIZE AND FUNCTION IN SICKLE CELL DISEASE
19. S265: RADIOMICS AND ARTIFICIAL INTELLIGENCE FOR IDENTIFICATION AND MONITORING OF SILENT CEREBRAL INFARCTS IN SICKLE CELL DISEASE: FIRST ANALYSIS FROM THE GENOMED4ALL EUROPEAN PROJECT
20. P1478: INTEGRATIVE DIAGNOSIS OF SICKLE CELL DISEASE PATIENTS FOR PERSONALIZED MEDICINE
21. S283: ERN-EUROBLOODNET EUROPEAN REGISTRY OF PATIENTS AFFECTED BY RED BLOOD CELL DISORDERS AND COVID-19
22. P1487: SICKLE CELL HEALTH AWARENESS, PERSPECTIVES AND EXPERIENCES (SHAPE) SURVEY: FINDINGS ON THE BURDEN OF SICKLE CELL DISEASE ON PATIENTS AND THEIR UNMET NEEDS AS REPORTED BY HEALTHCARE PROFESSIONALS
23. P1467: HEALTHCARE PROFESSIONALS (HCP) OPINIONS ON TREATMENTS FOR SICKLE CELL DISEASE (SCD) AND THE HCP–PATIENT RELATIONSHIP: RESULTS FROM THE INTERNATIONAL SICKLE CELL WORLD ASSESSMENT SURVEY (SWAY)
24. 'Where Is the Sun' for Hemi-Neglect Patients?
25. Drepanocitosis en el niño
26. Processing temporal events simultaneously in healthy human adults and in hemi-neglect patients
27. Exploration d’une anémie microcytaire chez l’enfant
28. S122: SAFETY AND EFFICACY OF CRIZANLIZUMAB IN ADOLESCENTS WITH SICKLE CELL DISEASE (SCD): INITIAL DATA FROM THE PHASE II, MULTICENTER, OPEN-LABEL SOLACE-KIDS TRIAL
29. S131: REGIONAL ASSESSMENT OF THE EXPERIENCES OF HEALTHCARE PROFESSIONALS (HCPS) TREATING PATIENTS WITH SICKLE CELL DISEASE (SCD): THE INTERNATIONAL SICKLE CELL WORLD ASSESSMENT SURVEY (SWAY)
30. Plasma Growth Hormone-Binding Protein and Liver Receptor in Thalassemic Patients
31. Facteurs de risque de COVID-19 sévère chez des patients drépanocytaires hospitalisés : étude nationale Française chez 319 patients
32. Caractéristiques des patients drépanocytaires infectés par le SARS-CoV-2 en fonction de leur prise en charge ambulatoire ou en hospitalisation : étude nationale chez 536 patients
33. The vertical–horizontal illusion in hemi-spatial neglect
34. “Where is the sun” for hemi-neglect patients?
35. Effect of hydroxyurea exposure before puberty on sperm parameters in males with sickle cell disease
36. CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia
37. SWG of red cell and iron of EHA and EuroBloodNet. Recommendations for diagnosis and treatment of methemoglobinemia
38. Traitement des patients drépanocytaires par hydroxyurée : efficacité et tolérance
39. Vaso-occlusive crisis of the temporo-mandibular joint: An unusual finding in sickle cell disease
40. Fonction myocardique et pathologie endothéliale dans la drépanocytose
41. Cerebrovascular complications in children with sickle cell disease
42. Antibiotic prevention of pneumococcal infections in asplenic hosts: admission of insufficiency
43. Myocardial ischaemia in children with sickle cell disease
44. Couverture vaccinale vis-à-vis de la grippe chez les enfants de la région parisienne atteints d'une affection de longue durée
45. Talasemias en el niño
46. Drepanocitosis en el niño
47. Osteopenia and vitamin D deficiency in children with sickle cell disease
48. Hodgkin lymphoma in a sickle cell anaemia child treated with hydroxyurea
49. Pneumococcal prophylaxis for children with sickle cell disease in Africa
50. Gadolinium-DOTA enhanced MRI of painful osseous crises in children with sickle cell anemia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.